RUNX2 and ovarian cancer: To clarify whether RUNX2 was involved in the miR-218-mediated tumor suppressive effects in ovarian cancer cells, we performed a restoration experiment by co-transfecting RUNX2 and miR-218 mimic into ovarian cancer cells.